You are here

Article Text

Article menu
Download PDFPDF
LETTER
Methaemoglobinaemia with concurrent blood isolation of Saccharomyces and Candida
  1. M S Lungarotti,
  2. D Mezzetti,
  3. M Radicioni
  1. Policlinico Monteluce, Via Brunamonti, Perugia, PG 06100, Italy; dm2@unipg.it

    https://doi.org/10.1136/fn.88.5.F446

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

      Saccharomyces boulardii is closely related to Saccharomyces cerevisiae and is used as biotherapeutic agent,1 although some reports suggest pathogenicity.2 We present a case of neonatal fungaemia with concurrent methaemoglobinaemia, occurring after a brief period of treatment with S boulardii. A male infant was born at 30 weeks of gestational age by caesarean section because of intrauterine growth restriction and maternal hypertension. The baby was well apart from persistent gastrointestinal symptoms that hampered feeding and forced parenteral support. During the …

      View Full Text